Search - tctmd.com

Displaying 1 - 20 of 104

Sort: Relevancy | Date

News Daily News

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

Todd Neale

December 05, 2025

News Daily News

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

L.A. McKeown

June 05, 2025

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

Presentation THT 2025

Mitigating Post-Operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study

Presenter: Anthony Kanelidis

February 13, 2025

Presentation THT 2025

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Presenter: Mary Acosta

February 12, 2025

Presentation THT 2025

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 12, 2025

Presentation THT Abstracts 2025

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

February 11, 2025

Presentation THT Abstracts 2025

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Presenter: Kanika Mody

February 11, 2025

Presentation THT Abstracts 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 11, 2025

Presentation THT Abstracts 2025

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Presenter: John DePietro

February 11, 2025

Presentation THT Abstracts 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT 2025

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Presenter: Boaz Elad

February 11, 2025

Presentation THT 2025

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Presenter: John DePietro

February 11, 2025

News Daily News

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Todd Neale

January 23, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Palliative Care in HF: Practical Advice From the HFSA

Caitlin E. Cox

December 05, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

Advertisement

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Mitigating Post-Operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Palliative Care in HF: Practical Advice From the HFSA

November 2024 Dispatch for the CV Team

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content